Reuters logo
Pfizer, J&J Alzheimer's drug fails one of 4 big trials
July 23, 2012 / 9:19 PM / 5 years ago

Pfizer, J&J Alzheimer's drug fails one of 4 big trials

July 23 (Reuters) - Pfizer Inc said on Monday its experimental Alzheimer’s disease treatment failed to prove effective in one of four high-stakes late-stage trials of the medicine.

The trial involved individuals who carry a variation of a gene called ApoE4 that makes them far more likely to develop Alzheimer’s disease. Pfizer said it and its partner Johnson & Johnson will continue with three other late-stage trials of their medicine, called bapineuzumab, based upon a review by independent safety monitors.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below